Concepedia

M. Khair ElZarrad

MK

11

Publications

782

Citations

10

H-Index

2010

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Cancer Institute

National Institutes of Health

Cancer Genetics (United States)

M. Khair ElZarrad is an author at United States Food and Drug Administration specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

2010–2022

11

Publications

11

GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier

Mike Cullen, M. Khair ElZarrad, Steven Seaman et al. · Proceedings of the National Academy of Sciences · 2011 · 213 citations · Full text

Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice

M. Khair ElZarrad, Partha Mukhopadhyay, Nishant Mohan et al. · PLoS ONE · 2013 · 135 citations · Full text

, , +19

Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes

Nishant Mohan, Yi Shen, Yukinori Endo et al. · Molecular Cancer Therapeutics · 2016 · 127 citations · Full text

Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021

Qi Liu, Ruihao Huang, Julie Hsieh et al. · Clinical Pharmacology & Therapeutics · 2022 · 76 citations · Full text

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Karim A. Calis, Patrick Archdeacon, Raymond P. Bain et al. · Clinical Trials · 2017 · 57 citations · Full text

Rows per page

1–5 of 11